BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Cla

GlobeNewsWire • 10 hours ago

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

NEW ORLEANS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX), if they purchased or otherwise acquired the Company's common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

GlobeNewsWire • 2 hours ago

BBNX 5-DAY DEADLINE ALERT: Beta Bionics Investors with Losses Encouraged to Contact Hagens Berman, Securities Class Action Pending

SAN FRANCISCO, Oct. 29, 2026 /PRNewswire/ -- Hagens Berman reminds investors in Beta Bionics, Inc. (NASDAQ: BBNX) of the pending securities class action lawsuit and upcoming November 3, 2026 lead plaintiff deadline under the Private Securities Litigation Reform Act (PSLRA). Investors who suffered substantial losses purchasing Beta Bionics stock during the Class Period between July 30, 2025 and February 24, 2026, inclusive, are encouraged to submit your losses now  to Hagens Berman to discuss their legal options.

PRNewsWire • 11 hours ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBNX

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

PRNewsWire • 10 hours ago

BBNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Beta Bionics, Inc. Securities Lawsuit - Contact SueWallSt

Disclosure under scrutiny: the lawsuit contends Beta Bionics' SEC filings described the FDA's Warning Letter as flagging "non-conformities" in its Quality Management System while allegedly omitting that hundreds of unreported iLet complaints involved life-threatening hypoglycemia. NEW YORK, Oct. 29, 2026 /PRNewswire/ -- SueWallSt notifies investors in Beta Bionics, Inc. (NASDAQ: BBNX) that a securities class action has been filed on behalf of shareholders who purchased securities between July 30, 2025 and February 24, 2026.

PRNewsWire • 10 hours ago

BBNX November 3, 2026 Lead Plaintiff Deadline - Robbins LLP Remonds Beta Bionics, Inc. Investors of the Opportunity to Lead the Securities Class Action Lawsuit

SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Beta Bionics, Inc. (NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the "Class Period"). Beta Bionics is a commercial-stage medical device company that offers an automated insulin delivery system for the treatment of diabetes, known as the iLet Bionic Pancreas insulin pump (“iLet”).

GlobeNewsWire • 11 hours ago

BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline. So what: If you purchased Beta Bionics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

PRNewsWire • an hour ago

Beta Bionics Investors Should Contact Block & Leviton Before November 3 to Lead Securities Fraud Class Action

Boston, Massachusetts--(Newsfile Corp. - October 29, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) and certain of its executives. Investors who have lost money in their Beta Bionics, Inc. investment should contact the firm to learn more about how they might recover those losses.

Newsfile Corp • 4 hours ago

Kaplan Fox Notifies Investors: Beta Bionics, Inc. (BBNX) Faces a Securities Class Action With a November 3, 2026 Deadline

New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us.

Newsfile Corp • 16 hours ago

Deadline Alert: Beta Bionics, Inc. Investors Have Until November 3, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

Class action covers investors who bought Beta Bionics, Inc. securities between July 30, 2025 and February 24, 2026; complaint alleges the company failed to disclose material adverse facts Class action covers investors who bought Beta Bionics, Inc. securities between July 30, 2025 and February 24, 2026; complaint alleges the company failed to disclose material adverse facts

GlobeNewsWire • Oct 28, 2026